48m
GENFIT Annual Combined General Meeting of June 15, 2026 — Availability of Preparatory Documents
Zurich (Switzerland), May 11, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results